| Primary |
| Glaucoma |
38.1% |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
7.9% |
| Intraocular Pressure Increased |
5.9% |
| Open Angle Glaucoma |
4.5% |
| Hypertension |
3.2% |
| Dry Eye |
2.9% |
| Ocular Hypertension |
2.2% |
| Intraocular Pressure Test |
1.9% |
| Normal Tension Glaucoma |
1.7% |
| Blood Pressure |
1.0% |
| Angle Closure Glaucoma |
0.8% |
| Headache |
0.8% |
| Supplementation Therapy |
0.8% |
| Osteoporosis |
0.7% |
| Blood Cholesterol Increased |
0.6% |
| Hypothyroidism |
0.6% |
| Asthma |
0.5% |
| Cataract Operation Complication |
0.5% |
| Chronic Obstructive Pulmonary Disease |
0.5% |
|
| Ocular Hyperaemia |
14.4% |
| Eye Irritation |
11.0% |
| Intraocular Pressure Increased |
8.6% |
| Eye Pain |
8.4% |
| Vision Blurred |
7.6% |
| Visual Acuity Reduced |
6.8% |
| Growth Of Eyelashes |
4.2% |
| Headache |
4.2% |
| Visual Field Defect |
4.2% |
| Skin Hyperpigmentation |
3.7% |
| Conjunctival Hyperaemia |
3.1% |
| Eye Pruritus |
3.1% |
| Death |
2.9% |
| Rash |
2.9% |
| Visual Impairment |
2.9% |
| Blood Pressure Increased |
2.6% |
| Drug Ineffective |
2.6% |
| Dry Eye |
2.4% |
| Erythema |
2.4% |
| Retinal Detachment |
2.1% |
|
| Secondary |
| Glaucoma |
47.1% |
| Product Used For Unknown Indication |
13.0% |
| Intraocular Pressure Increased |
7.1% |
| Hypertension |
5.6% |
| Open Angle Glaucoma |
4.6% |
| Drug Use For Unknown Indication |
2.8% |
| Normal Tension Glaucoma |
2.2% |
| Angle Closure Glaucoma |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Cataract |
1.9% |
| Intraocular Pressure Test |
1.6% |
| Ocular Hypertension |
1.6% |
| Arrhythmia |
1.5% |
| Cardiac Disorder |
1.1% |
| Dry Eye |
1.1% |
| Growth Of Eyelashes |
1.0% |
| Hypersensitivity |
1.0% |
| Abnormal Sensation In Eye |
0.9% |
| Arthritis |
0.9% |
| Diabetes Mellitus |
0.9% |
|
| Ocular Hyperaemia |
12.3% |
| Drug Ineffective |
8.5% |
| Pruritus |
7.7% |
| Growth Of Eyelashes |
6.9% |
| Headache |
6.9% |
| Eye Irritation |
5.4% |
| Eye Pain |
4.6% |
| Intraocular Pressure Increased |
4.6% |
| Thyroid Cancer |
4.6% |
| Vision Blurred |
4.6% |
| Visual Field Defect |
4.6% |
| Drug Hypersensitivity |
3.8% |
| Visual Impairment |
3.8% |
| Conjunctival Hyperaemia |
3.1% |
| Conjunctivitis Allergic |
3.1% |
| Death |
3.1% |
| Skin Burning Sensation |
3.1% |
| Skin Discolouration |
3.1% |
| Vitreous Haemorrhage |
3.1% |
| Vomiting |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.5% |
| Glaucoma |
19.5% |
| Drug Use For Unknown Indication |
12.0% |
| Hypertension |
8.1% |
| Diabetes Mellitus |
3.9% |
| Osteoporosis |
3.4% |
| Atrial Fibrillation |
3.2% |
| Pain |
3.1% |
| Blood Cholesterol Increased |
2.8% |
| Type 2 Diabetes Mellitus |
2.1% |
| Depression |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Prophylaxis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Asthma |
1.6% |
| Cardiac Disorder |
1.5% |
| Hepatitis C |
1.4% |
| Non-small Cell Lung Cancer |
1.2% |
| Intraocular Pressure Increased |
1.1% |
|
| Vision Blurred |
12.9% |
| Weight Decreased |
9.4% |
| Vomiting |
6.9% |
| Wheezing |
6.6% |
| Visual Acuity Reduced |
6.2% |
| Intraocular Pressure Increased |
5.8% |
| Weight Increased |
5.2% |
| Rash |
4.9% |
| Ocular Hyperaemia |
4.5% |
| Pain In Extremity |
3.9% |
| Urinary Tract Infection |
3.7% |
| Death |
3.6% |
| Fatigue |
3.6% |
| Wrist Fracture |
3.6% |
| Pain |
3.4% |
| Pruritus |
3.4% |
| Drug Ineffective |
3.2% |
| Eye Irritation |
3.2% |
| Glaucoma |
3.2% |
| Hypertension |
3.0% |
|
